Holocene Advisors, LP Sutro Biopharma, Inc. Transaction History

Holocene Advisors, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$4.48 - $8.45 $809,397 - $1.53 Million	-180,669 Reduced 7.81%	2,132,873 $9.85 Million
Q4 2022 Feb 14, 2023	SELL	$5.41 - $8.08 $2.66 Million - $3.97 Million	-491,655 Reduced 17.53%	2,313,542 $18.7 Million
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $3.32 Million - $8.71 Million	973,442 Added 53.14%	2,805,197 $14.6 Million
Q1 2022 May 16, 2022	BUY	$7.78 - $15.31 $1.93 Million - $3.8 Million	248,176 Added 15.67%	1,831,755 $15.1 Million
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $340,389 - $562,061	-23,887 Reduced 1.49%	1,583,579 $23.6 Million
Q3 2021 Nov 15, 2021	BUY	$16.88 - $22.38 $178,657 - $236,869	10,584 Added 0.66%	1,607,466 $30.4 Million
Q2 2021 Aug 16, 2021	BUY	$18.03 - $23.82 $3.13 Million - $4.14 Million	173,677 Added 12.2%	1,596,882 $29.7 Million
Q1 2021 May 17, 2021	BUY	$20.29 - $27.54 $7.22 Million - $9.8 Million	355,947 Added 33.35%	1,423,205 $32.4 Million
Q4 2020 Feb 16, 2021	BUY	$10.16 - $23.98 $10.8 Million - $25.6 Million	1,067,258 New	1,067,258 $23.2 Million

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $139M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.